pdei1 progst1
Name
premar1
Label
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1))
Description

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the Sleep Heart Health Study Visit One (SHHS1) visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
hormone therapy medication_form_shhs
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1)) vs Sleep Heart Health Study (SHHS) Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total 5,804 - - -
No 5,049 - - -
Yes 737 - - -
Unknown 18 - - -
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1)) vs Age at Sleep Heart Health Study Visit One (SHHS1)
Visit 1
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 342 1,017 1,769 1,617 955 104 5,804
No 333 887 1,420 1,444 867 98 5,049
Yes 3 126 346 171 85 6 737
Unknown 6 4 3 2 3 - 18
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1)) vs Gender of the participant
Visit 1
Male Female Total
Total 2,765 3,039 5,804
No 2,750 2,299 5,049
Yes 4 733 737
Unknown 11 7 18
Premarin (Conjugated Estrogens) (Sleep Heart Health Study Visit One (SHHS1)) vs Race of the participant
Visit 1
White Black Other Total
Total 4,907 515 382 5,804
No 4,221 479 349 5,049
Yes 676 31 30 737
Unknown 10 5 3 18